Chronic critical limb ischemia (CLI), defined as > 2 weeks of rest pain, ulcers, or tissue loss attributed to arterial occlusive disease, is associated with great loss of both limb and life. Therapeutic goals in treating patients with CLI include reducing cardiovascular risk factors, relieving ischemic pain, healing ulcers, preventing major amputation, improving quality of life and increasing survival. These aims may be achieved through medical therapy, revascularization, or amputation. Medical therapy includes administration of analgesics, local wound care and pressure relief, treatment of infection, and aggressive therapy to modify atherosclerotic risk factors. For patients who are not candidates for revascularization, and who are unwilling or unable to undergo amputation, treatments such as intermittent pneumatic compression or spinal cord stimulation may offer symptom relief and promote wound healing. Revascularization offers the best option for limb salvage. The decision to perform surgery, endovascular therapy, or a combination of the two modalities (‘hybrid’ therapy) must be individualized. Patients who are relatively fit and able to withstand the rigors of an open procedure may benefit from the long-term durability of surgical repair. In contrast, frail patients with a limited life expectancy may experience better outcomes with endovascular reconstruction. Hybrid therapy is an attractive option for patients with limited autologous conduit, as it permits complete revascularization with a less extensive procedure, shorter duration of operation, and decreased risk of peri-operative complications. Amputation should be considered for patients who are non-ambulatory, demented, or unfit to undergo revascularization.
2 Sumpio BE . Foot ulcers. N Engl J Med2000; 343: 787–793.
3.
3 Rossi M Carpi A . Skin microcirculation in peripheral arterial obliterative disease. Biomed Pharmacother2004; 58: 427–431.
4.
4 Holmberg A Sandhagen B Bergqvist D . Hemorheologic variables in critical limb ischemia before and after infrainguinal reconstruction. J Vasc Surg2000; 31: 691–695.
5.
5 Vogt MT McKenna M Wolfson SK Kuller LH . The relationship between ankle brachial index, other atherosclerotic disease, diabetes, smoking and mortality in older men and women. Atherosclerosis1993; 101: 191–202.
6.
6 Silvestro A Diehm N Savolainen H . Falsely high ankle–brachial index predicts major amputation in critical limb ischemia. Vasc Med2006; 11: 69–74.
7.
7 De Graaff JC Ubbink DT Legemate DA Tijssen JG Jacobs MJ . Evaluation of toe pressure and transcutaneous oxygen measurements in management of chronic critical leg ischemia: a diagnostic randomized clinical trial. J Vasc Surg2003; 38: 528–534.
8.
8 Ubbink DT Spincemaille GH Prins MH Reneman RS Jacobs MJ . Microcirculatory investigations to determine the effect of spinal cord stimulation for critical leg ischemia: the Dutch multicenter randomized controlled trial. J Vasc Surg1999; 30: 236–244.
9.
9 Ubbink DT Spincemaille GH Reneman RS Jacobs MJ . Prediction of imminent amputation in patients with non-reconstructible leg ischemia by means of microcirculatory investigations. J Vasc Surg1999; 30: 114–121.
10.
10 Bertele V Roncaglioni MC Pangrazzi J Terzian E Tognoni EG . Clinical outcome and its predictors in 1560 patients with critical leg ischaemia. Chronic Critical Leg Ischaemia Group. Eur J Vasc Endovasc Surg1999; 18: 401–410.
11.
11 Varty K Nydahl S Nasim A Bolia A Bell PR London JM . Results of surgery and angioplasty for the treatment of chronic severe lower limb ischaemia. Eur J Vasc Endovasc Surg1998; 16: 159–163.
12.
12 Dorros G Jaff MR Dorros AM Mathiak LM He T . Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation2001; 104: 2057–2062.
13.
13 Mangano DT Layug EL Wallace A Tateo I . Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med1996; 335: 1713–1720.
14.
14 Poldermans D Boersma E Bax JJ . The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med1999; 341: 1789–1794.
15.
15 MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet2002; 360: 7–22.
16.
16 Conte MS Bandyk DF Clowes AW Moneta GL Namini H Seely L . Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg2005; 42: 456–464; discussion 464–465.
17.
17 Raghunathan A Rapp JH Littooy F . Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial. J Vasc Surg2006; 43: 1175–1182.
18.
18 Montori VM Kavros SJ Walsh EE Rooke TW . Intermittent compression pump for nonhealing wounds in patients with limb ischemia. The Mayo Clinic experience (1998–2000). Int Angiol2002; 21: 360–366.
19.
19 Kavros SJ Delis KT Turner NS . Improving limb salvage in critical limb ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up. J Vasc Surg2008; 47: 543–549.
20.
20 Amann W Berg P Gersbach P Gamain J Raphael JH Ubbink DT . Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg2003; 26: 280–286.
21.
21 Ubbink DT Vermeulen H . Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev2003; 3: CD004001.
22.
22 Lantsberg L Goldman M . Lower limb sympathectomy assessed by laser Doppler blood flow and transcutaneous oxygen measurements. J Med Eng Technol1990; 14: 182–183.
23.
23 Holiday FA Barendregt WB Slappendel R Crul BJ Buskens FG van der Vliet JA . Lumbar sympathectomy in critical limb ischaemia: surgical, chemical or not at all. Cardiovasc Surg1999; 7: 200–202.
24.
24 Dormandy J . Use of the prostacyclin analogue iloprost in the treatment of patients with critical limb ischaemia. Therapie1991; 46: 319–322.
25.
25 Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group. Eur J Vasc Endovasc Surg2000; 20: 358–362.
26.
26 Brass EP Anthony R Dormandy J . Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg2006; 43: 752–759.
27.
27 Nehler MR Brass EP Anthony R . Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. J Vasc Surg2007; 45: 953–960; discussion 960–961.
28.
28 Kolvenbach R Kreissig C Ludwig E Cagiannos C . Stem cell use in critical limb ischemia. J Cardiovasc Surg (Torino)2007; 48: 39–44.
29.
29 Tateishi-Yuyama E Matsubara H Murohara T . Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet2002; 360: 427–435.
30.
30 Kudo FA Nishibe T Nishibe M Yasuda K . Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. Int Angiol2003; 22: 344–348.
31.
31 Marui A Tabata Y Kojima S . A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study. Circ J2007; 71: 1181–1186.
32.
32 Rajagopalan S Olin J Deitcher S . Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience. Circulation2007; 115: 1234–1243.
33.
33 Enoch S Grey JE Harding KG . ABC of wound healing. Non-surgical and drug treatments. BMJ2006; 332: 900–903.
34.
34 Eginton MT Brown KR Seabrook GR Towne JB Cambria RA . A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds. Ann Vasc Surg2003; 17: 645–649.
35.
35 Kavros SJ Miller JL Hanna SW . Treatment of ischemic wounds with noncontact, low-frequency ultrasound: the Mayo clinic experience, 2004–2006. Adv Skin Wound Care2007; 20: 221–226.
36.
36 Kranke P Bennett M Roeckl-Wiedmann I Debus S . Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev2004; 2: CD004123.
37.
37 Steed DL . Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg1995; 21: 71–78; discussion 79–81.
38.
38 Marston WA Davies SW Armstrong B . Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg2006; 44: 108–114.
39.
39 Hertzer NR Bena JF Karafa MT . A personal experience with direct reconstruction and extra-anatomic bypass for aortoiliofemoral occlusive disease. J Vasc Surg2007; 45: 527–535; discussion 535.
40.
40 McDaniel MD Macdonald PD Haver RA Littenberg B . Published results of surgery for aortoiliac occlusive disease. Ann Vasc Surg1997; 11: 425–441.
41.
41 Zukauskas G Ulevicius H Janusauskas E . An optimal inflow procedure for multi-segmental occlusive arterial disease: ilio-femoral versus aorto-bifemoral bypass. Cardiovasc Surg1998; 6: 250–255.
42.
42 De Vries SO Hunink MG . Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg1997; 26: 558–569.
43.
43 Back MR Johnson BL Shames ML Bandyk DF . Evolving complexity of open aortofemoral reconstruction done for occlusive disease in the endovascular era. Ann Vasc Surg2003; 17: 596–603.
44.
44 Rouers A Meurisse N Lavigne JP . Potential benefits of laparoscopic aorto-bifemoral bypass surgery. Acta Chir Belg2005; 105: 610–615.
45.
45 Fourneau I Daenens K Nevelsteen A . Hand-assisted laparoscopic aortobifemoral bypass for occlusive disease. Early and mid-term results. Eur J Vasc Endovasc Surg2005; 30: 489–493.
46.
46 Timaran CH Prault TL Stevens SL Freeman MB Goldman MH . Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg2003; 38: 272–278.
47.
47 Upchurch GR Dimick JB Wainess RM . Diffusion of new technology in health care: the case of aorto-iliac occlusive disease. Surgery2004; 136: 812–818.
48.
48 Conte MS Bandyk DF Clowes AW . Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg2006; 43: 742–751; discussion 751.
49.
49 Johnson WC Lee KK . A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg2000; 32: 268–277.
50.
50 Pereira CE Albers M Romiti M Brochado-Neto FC Pereira CA . Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg2006; 44: 510–517.
51.
51 Pomposelli FB Kansal N Hamdan AD . A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg2003; 37: 307–315.
52.
52 Adam DJ Beard JD Cleveland T . Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet2005; 366: 1925–1934.
53.
53 Ballotta E Renon L De Rossi A Barbon B Terranova O Da Giau G . Prospective randomized study on reversed saphenous vein infrapopliteal bypass to treat limb-threatening ischemia: common femoral artery versus superficial femoral or popliteal and tibial arteries as inflow. J Vasc Surg2004; 40: 732–740.
54.
54 Albers M Romiti M Brochado-Neto FC Pereira CA . Meta-analysis of alternate autologous vein bypass grafts to infrapopliteal arteries. J Vasc Surg2005; 42: 449–455.
55.
55 Klinkert P van Dijk PJ Breslau PJ . Polytetrafluoroethylene femorotibial bypass grafting: 5-year patency and limb salvage. Ann Vasc Surg2003; 17: 486–491.
56.
56 Desai TR Meyerson SL Skelly CL . Patency and limb salvage after infrainguinal bypass with severely compromised (‘blind’) outflow. Arch Surg2001; 136: 635–642.
57.
57 Abou-Zamzam AM Lee RW Moneta GL Taylor LM Porter JM . Functional outcome after infrainguinal bypass for limb salvage. J Vasc Surg1997; 25: 287–295; discussion 295–297.
58.
58 Haider SN Kavanagh EG Forlee M . Two-year outcome with preferential use of infrainguinal angioplasty for critical ischemia. J Vasc Surg2006; 43: 504–512.
59.
59 Dosluoglu HH O’Brien-Irr MS Lukan J Harris LM Dryjski ML Cherr GS . Does preferential use of endovascular interventions by vascular surgeons improve limb salvage, control of symptoms, and survival of patients with critical limb ischemia. Am J Surg2006; 192: 572–576.
60.
60 Kudo T Chandra FA Ahn SS . The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg2005; 41: 423–435; discussion 435.
61.
61 Kudo T Chandra FA Kwun WH Haas BT Ahn SS . Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg2006; 44: 304–313.
62.
62 Tefera G Hoch J Turnipseed WD . Limb-salvage angioplasty in vascular surgery practice. J Vasc Surg2005; 41: 988–993.
63.
63 Arain SA White CJ . Endovascular therapy for critical limb ischemia.Vasc Med2008 13: 267–280.
64.
64 Melliere D Cron J Allaire E Desgranges P Becquemin JP . Indications and benefits of simultaneous endoluminal balloon angioplasty and open surgery during elective lower limb revascularization. Cardiovasc Surg1999; 7: 242–246.
65.
65 Miyahara T Miyata T Shigematsu H . Long-term results of combined iliac endovascular intervention and infrainguinal surgical revascularization for treatment of multilevel arterial occlusive disease. Int Angiol2005; 24: 340–348.
66.
66 Schneider PA Caps MT Ogawa DY Hayman ES . Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene. J Vasc Surg2001; 33: 955–962.
67.
67 Cotroneo AR Iezzi R Marano G Fonio P Nessi F Gandini G . Hybrid therapy in patients with complex peripheral multifocal steno-obstructive vascular disease: two-year results. Cardiovasc Intervent Radiol2007; 30: 355–361.
68.
68 Dougherty MJ Young LP Calligaro KD . One hundred twenty-five concomitant endovascular and open procedures for lower extremity arterial disease. J Vasc Surg2003; 37: 316–322.
69.
69 Leville CD Kashyap VS Clair DG . Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. J Vasc Surg2006; 43: 32–39.
70.
70 Nelson PR Powell RJ Schermerhorn ML . Early results of external iliac artery stenting combined with common femoral artery endarterectomy. J Vasc Surg2002; 35: 1107–1113.
71.
71 Schanzer A Owens CD Conte MS Belkin M . Superficial femoral artery percutaneous intervention is an effective strategy to optimize inflow for distal origin bypass grafts. J Vasc Surg2007; 45: 740–743.
72.
72 Goshima KR Mills JL Hughes JD . A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J Vasc Surg2004; 39: 330–335.
73.
73 Nguyen LL Lipsitz SR Bandyk DF . Resource utilization in the treatment of critical limb ischemia: the effect of tissue loss, comorbidities, and graft-related events. J Vasc Surg2006; 44: 971–975; discussion 975–976.
74.
74 Chung J Bartelson BB Hiatt WR . Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia. J Vasc Surg2006; 43: 1183–1190.
75.
75 Nicoloff AD Taylor LM McLafferty RB Moneta GL Porter JM . Patient recovery after infrainguinal bypass grafting for limb salvage. J Vasc Surg1998; 27: 256–263; discussion 264–266.
76.
76 Rutherford RB Baker JD Ernst C . Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg1997; 26: 517–538.
77.
77 Taylor SM Cull DL Kalbaugh CA . Critical analysis of clinical success after surgical bypass for lower-extremity ischemic tissue loss using a standardized definition combining multiple parameters: a new paradigm of outcomes assessment. J Am Coll Surg2007; 204: 831–838; discussion 838–839.
78.
78 Nguyen LL Moneta GL Conte MS Bandyk DF Clowes AW Seely BL . Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg2006; 44: 977–983; discussion 983–984.
79.
79 Deutschmann HA Schoellnast H Temmel W . Endoluminal therapy in patients with peripheral arterial disease: prospective assessment of quality of life in 190 patients. AJR Am J Roentgenol2007; 188: 169–175.
80.
80 Kalbaugh CA Taylor SM Cull DL . Invasive treatment of chronic limb ischemia according to the Lower Extremity Grading System (LEGS) score: a 6-month report. J Vasc Surg2004; 39: 1268–1276.
81.
81 Jamsen T Manninen H Tulla H Matsi P . The final outcome of primary infrainguinal percutaneous transluminal angioplasty in 100 consecutive patients with chronic critical limb ischemia. J Vasc Interv Radiol2002; 13: 455–463.
82.
82 Stone PA Flaherty SK Aburahma AF . Factors affecting perioperative mortality and wound-related complications following major lower extremity amputations. Ann Vasc Surg2006; 20: 209–216.
83.
83 Aulivola B Hile CN Hamdan AD . Major lower extremity amputation: outcome of a modern series. Arch Surg2004; 139: 395–399; discussion 399.
84.
84 Nehler MR Coll JR Hiatt WR . Functional outcome in a contemporary series of major lower extremity amputations. J Vasc Surg2003; 38: 7–14.
85.
85 Taylor SM Kalbaugh CA Blackhurst DW Kellicut DC Langan EM Youkey JR . A comparison of percutaneous transluminal angioplasty versus amputation for critical limb ischemia in patients unsuitable for open surgery. J Vasc Surg2007; 45: 304–310; discussion 310–311.
86.
86 Taylor SM Kalbaugh CA Blackhurst DW . Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions. J Vasc Surg2006; 44: 747–755; discussion 755–756.
87.
87 Taylor SM Kalbaugh CA Blackhurst DW . Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patients. J Vasc Surg2005; 42: 227–235.
